Reflection - Road to Innovation

CEO Communique
Date:  2019-05-20
Author:   Dr. Sean Hall

Sorry about the delay in publishing this communique, as some of you know, the pace is frantic here at Medlab.

April was a record month and a strong indication of what is yet to come, but it’s important to understand, this was not because of serendipity.

For the past few years, my team has been researching (arguing), designing (some more arguing) and developing unique, innovative products based on our research.

Yes, there was a bit of spirited conversation, but this helps bring out the best in us – you see, at Medlab research pushes innovation, innovation pushes barriers, and moving barriers promotes patents. These patents cover techniques and/or products.

And it’s these products that offer reliability, uniqueness and competitive advantage.

To this, our nutraceuticals have rolled out into pharmacy and to date, the feedback has been better than anticipated.

But irrespective of nutraceutical or pharmaceutical, this research takes time; so to this end, it’s fantastic to see our progression and more-so, the positive impact my Medlab team make to the lives of others.

I am constantly encouraged and humbled by the efforts of my team and for this, I am thankful.

Today Medlab has made a significant step forward in our fundamental culture, to offer more choice, more therapeutic options, and more hope to those with chronic illness.

It’s eloquent considering our in-store branding is

More soon,

COMMENTS 0

Tell us what you think login to share your thoughts.

ABOUT THE AUTHOR

Dr. Sean Hall, Chief Executive Officer of Medlab
Chief Executive Officer
Dr. Sean Hall

Sean founded Medlab in August 2012; he has over 20 years' experience in nutraceutical sales and development, as well as early drug discovery in Australia, Asia and the US. Sean has led and inspired his teams to author multiple patents, write peer-reviewed articles and deliver lectures at scientific conferences. His passion is leading his researchers into novel areas and strong commercialisation opportunities.

Prior Sean was a founder of FIT-BioCeuticals. Under his management and guidance, BioCeuticals became the most innovative, research-driven, practitioner brand in Australia. For his sale of FIT-BioCeuticals to Blackmores in 2012, Sean was nominated as a finalist in the inaugural Australian Exit CEO of the Year Award. Sean is a Medical Doctor with an MBA in clinical pharmaceutical management and focuses on the research to pioneer innovation and commercialisation. Sean is an active member of Medicines Australia, the European Medical Association, the American Federation for Medical Researcher, The World Medical Association, A4M and Special Operations Medical Association.